Vinblastine (NSC-49842) plus vincristine (NSC-67574) given in intensive 3-day courses as therapy for lymphomas, sarcomas, and other neoplasms.
作者信息
Stolinsky D C, Bogdon D L, Pugh R P, Braunwald J, Hestorff R, Bateman J R
出版信息
Cancer Chemother Rep. 1973 Nov-Dec;57(4):481-4.
PMID:4586955
Abstract
摘要
相似文献
1
2
3
DTIC (NSC-45388) studies in the southwest oncology group.西南肿瘤协作组中达卡巴嗪（NSC - 45388）的研究
Cancer Treat Rep. 1976 Feb;60(2):189-92.
4
Safety and tolerance of Navelbine in phase I-II clinical studies.诺维本在I-II期临床研究中的安全性与耐受性。
Semin Oncol. 1989 Apr;16(2 Suppl 4):37-40.
5
[Polychemotherapy with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) and vincristine (NSC-67574) in the metastatic phase of melanoma].[采用5-(3,3-二甲基-1-三氮烯基)咪唑-4-甲酰胺（达卡巴嗪；NSC-45388）、1,3-双(2-氯乙基)-1-亚硝基脲（卡莫司汀，NSC-409962）和长春新碱（NSC-67574）对黑色素瘤转移期进行多药化疗]
Tumori. 1973 May-Jun;59(3):239-48. doi: 10.1177/030089167305900305.
6
Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the Central Oncology Group.中央肿瘤学组中达卡巴嗪（NSC - 45388）的I期评估及其他恶性黑色素瘤研究
Cancer Treat Rep. 1976 Feb;60(2):183-7.
7
Phase II study of vindesine sulfate in the therapy for advanced renal carcinoma.
Cancer Treat Rep. 1977 Dec;61(9):1727-9.
8
Phase II evaluation of vindesine sulfate in patients with advanced sarcomas.硫酸长春地辛用于晚期肉瘤患者的II期评估。
Cancer Treat Rep. 1981 May-Jun;65(5-6):515-6.
9
A combination of cyclophosphamide, methotrexate, vincristine and VP 16-213 (NSC 141 540) in the treatment of bronchogenic carcinoma.
Tumori. 1977 Mar-Apr;63(2):169-73. doi: 10.1177/030089167706300207.
10
[Neurotoxicity of some antineoplastic agents].[某些抗肿瘤药物的神经毒性]
Boll Soc Ital Biol Sper. 1974 Sep 15;50(17):1333-59.
引用本文的文献
1
Phase I and pharmacokinetic study of IV vinflunine in cancer patients with liver dysfunction.肝功能障碍癌症患者静脉注射长春氟宁的 I 期和药代动力学研究。
Invest New Drugs. 2013 Jun;31(3):724-33. doi: 10.1007/s10637-012-9878-7. Epub 2012 Sep 21.
Zotero 插件